Afric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Founded in 1966, Afric Phar is a privately owned Moroccan pharmaceutical company that has evolved into a fully integrated operation, spanning production, marketing, sales and distribution. As one of the first pharmaceutical companies established entirely by Moroccan pharmacists, it has built a strong reputation within the local market. Specializing in the import, manufacturing and distribution of generic drugs, Afric Phar serves a wide range of therapeutic areas. The company has also expanded its product portfolio and market reach through strategic partnerships with leading European and multinational laboratories under licensing agreements.
Pharma Capital, part of the Sefrioui group, is a Moroccan joint-stock company. The company focuses on investments in the pharmaceutical sector and was established as a dedicated vehicle to execute this specific investment strategy.
The Chaoui family, founders and owners of Afric Phar, have been instrumental to the company’s success, guiding it through decades of growth and innovation in Morocco’s pharmaceutical sector.
Oaklins’ team in Morocco acted as the sell-side advisor for a group of the selling shareholders, responsible for structuring, executing and negotiating the transaction.
Talk to the deal team
Related deals
Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth
Dolmans Landscaping Group, a leading full-service provider of landscaping services, has welcomed Foreman Capital as a new shareholder. By partnering with Foreman Capital, which has extensive experience in building stronger companies in the maintenance of public spaces, Dolmans can accelerate its growth trajectory across core verticals and further professionalize the business.
Learn moreBackspin has completed a mandatory public tender offer for the shares of Spindox
Backspin S.p.A. has completed a mandatory public tender offer for Spindox S.p.A.
Learn moreBridgepoint has partnered with Exile Group to support its next phase of growth
Bridgepoint Group has partnered with Exile Group, a leading provider of proprietary data and intelligence to the trade, project and development finance markets. The transaction sees Bridgepoint Growth become a significant minority shareholder in Exile. Exile’s founders and management team will retain majority ownership and continue to lead the business.
Learn more